|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.880 SEK | +0.80% |
|
-14.55% | -1.05% |
| 20/07 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 16/07 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 456M 401M 373M 342M 643M 43.95B 653M 4.43B 1.73B 21.61B 1.71B 1.68B 74.7B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 424M 373M 347M 318M 597M 40.85B 607M 4.11B 1.61B 20.09B 1.59B 1.56B 69.44B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 1 week | -14.55% | ||
| Current month | -21.67% | ||
| 1 month | -24.80% | ||
| 3 months | -32.86% | ||
| 6 months | -4.81% | ||
| Current year | -1.05% |
| 1 week | 1.61 |  | 2.15 |
| 1 month | 1.61 | | 2.6 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 13.4 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 01/01/2011 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/7/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 1/4/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -14.55% | -30.37% | -34.49% | 47.05M | |
| +0.86% | +1.43% | +47.17% | +163.68% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.50% | 635B | |
| +0.95% | +1.91% | +36.30% | +82.78% | 458B | |
| +1.60% | +6.25% | +37.00% | +31.03% | 347B | |
| -0.60% | +1.52% | +36.67% | +41.41% | 295B | |
| -0.14% | +0.60% | +17.29% | +18.74% | 262B | |
| +0.09% | -2.82% | -29.09% | -39.57% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.87% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.52% | 161B | |
| Average | +0.52% | -0.26% | +20.54% | +44.35% | 364.36B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +79.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40.03M 37.23M 34.16M 64.18M 4.39B 65.17M 442M 173M 2.16B 171M 167M 7.46B | 53.9M 47.34M 44.03M 40.4M 75.91M 5.19B 77.08M 523M 204M 2.55B 202M 198M 8.82B |
| Net income | -53.18M -46.71M -43.44M -39.86M -74.89M -5.12B -76.05M -516M -202M -2.52B -200M -195M -8.71B | -51.89M -45.57M -42.38M -38.89M -73.08M -5B -74.2M -503M -197M -2.46B -195M -191M -8.49B |
| Net Debt | -73.01M -64.13M -59.64M -54.72M -103M -7.03B -104M -708M -277M -3.46B -274M -268M -11.95B | -32.11M -28.2M -26.23M -24.07M -45.22M -3.09B -45.92M -311M -122M -1.52B -121M -118M -5.26B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | SEK 1.880 | +0.80% | 104,975 |
| 23/07/26 | SEK 1.865 | +0.27% | 162,793 |
| 22/07/26 | SEK 1.860 | -9.27% | 392,131 |
| 21/07/26 | SEK 2.050 | -6.39% | 124,264 |
| 20/07/26 | SEK 2.190 | -0.45% | 54,536 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
